119 related articles for article (PubMed ID: 18313296)
21. Renin inhibition by synthetic peptides related to mouse and human renin prosegments.
Evin G; Cumin F; Ménard J; Corvol P; Fehrentz JA; Seyer R; Castro B
J Hypertens Suppl; 1984 Dec; 2(3):S227-9. PubMed ID: 6400368
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of human plasma renin activity by pepstatin.
Guyene TT; Devaux C; Menard J; Corvol P
J Clin Endocrinol Metab; 1976 Dec; 43(6):1301-6. PubMed ID: 12191
[TBL] [Abstract][Full Text] [Related]
23. Silanediol inhibitors of angiotensin-converting enzyme. Synthesis and evaluation of four diastereomers of Phe[Si]Ala dipeptide analogues.
Kim J; Hewitt G; Carroll P; Sieburth SM
J Org Chem; 2005 Jul; 70(15):5781-9. PubMed ID: 16018669
[TBL] [Abstract][Full Text] [Related]
24. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and heparanase inhibitory activity of sulfated mannooligosaccharides related to the antiangiogenic agent PI-88.
Fairweather JK; Hammond E; Johnstone KD; Ferro V
Bioorg Med Chem; 2008 Jan; 16(2):699-709. PubMed ID: 17967543
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory activities of Cassia tora and its anthraquinone constituents on angiotensin-converting enzyme.
Hyun SK; Lee H; Kang SS; Chung HY; Choi JS
Phytother Res; 2009 Feb; 23(2):178-84. PubMed ID: 18803227
[TBL] [Abstract][Full Text] [Related]
27. [Inhibition of IAA-induced growth of wheat coleoptile fragments by chitin-chitosan oligomers].
Khaĭrullin RM; Akhmetova IE; Iusupova ZR
Izv Akad Nauk Ser Biol; 2002; (2):172-5. PubMed ID: 11963543
[TBL] [Abstract][Full Text] [Related]
28. Design and preparation of potent, nonpeptidic, bioavailable renin inhibitors.
Bezençon O; Bur D; Weller T; Richard-Bildstein S; Remen L; Sifferlen T; Corminboeuf O; Grisostomi C; Boss C; Prade L; Delahaye S; Treiber A; Strickner P; Binkert C; Hess P; Steiner B; Fischli W
J Med Chem; 2009 Jun; 52(12):3689-702. PubMed ID: 19358611
[TBL] [Abstract][Full Text] [Related]
29. Chitooligosaccharides stimulate Atlantic salmon, Salmo salar L., head kidney leukocytes to enhanced superoxide anion production in vitro.
Hoffman J; Johansen A; Steiro K; Gildberg A; Stenberg E; Bøgwald J
Comp Biochem Physiol B Biochem Mol Biol; 1997 Sep; 118(1):105-15. PubMed ID: 9417999
[TBL] [Abstract][Full Text] [Related]
30. Renin inhibition and atherosclerosis.
Luft FC
Nephrol Dial Transplant; 2008 Aug; 23(8):2474-6. PubMed ID: 18430802
[No Abstract] [Full Text] [Related]
31. [Direct renin inhibition: a new and promising treatment principle in heart failure?].
Mahfoud F; Ukena C; Böhm M
Dtsch Med Wochenschr; 2009 Apr; 134(15):759-62. PubMed ID: 19340755
[No Abstract] [Full Text] [Related]
32. Antimicrobial effects of chitosans and chitooligosaccharides, upon Staphylococcus aureus and Escherichia coli, in food model systems.
Fernandes JC; Tavaria FK; Soares JC; Ramos OS; João Monteiro M; Pintado ME; Xavier Malcata F
Food Microbiol; 2008 Oct; 25(7):922-8. PubMed ID: 18721683
[TBL] [Abstract][Full Text] [Related]
33. In vitro xanthine oxidase inhibitory activity of the fractions of Erythrina stricta Roxb.
Umamaheswari M; Asokkumar K; Sivashanmugam AT; Remyaraju A; Subhadradevi V; Ravi TK
J Ethnopharmacol; 2009 Jul; 124(3):646-8. PubMed ID: 19467311
[TBL] [Abstract][Full Text] [Related]
34. [What is the purpose of dual or triple inhibition of the renin-angiotensin-aldosterone system?].
Legrand D; Krzesinski JM; Scheen AJ
Rev Med Suisse; 2008 Aug; 4(168):1792-7. PubMed ID: 18814762
[TBL] [Abstract][Full Text] [Related]
35. Renin inhibition: should it supplant ACE inhibitors and ARBS in high risk patients?
Gaddam KK; Oparil S
Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):484-90. PubMed ID: 18695389
[TBL] [Abstract][Full Text] [Related]
36. The effect of preparation processes on the physicochemical characteristics and antibacterial activity of chitooligosaccharides.
Sánchez Á; Mengíbar M; Rivera-Rodríguez G; Moerchbacher B; Acosta N; Heras A
Carbohydr Polym; 2017 Feb; 157():251-257. PubMed ID: 27987925
[TBL] [Abstract][Full Text] [Related]
37. [Inhibition of extracts from Synotis erythropappa on tyrosinase].
Xu XT; Zhang K; Du ZY; Zheng J; Fang YX; Wei XC; Zhao SQ; Yu XH
Zhong Yao Cai; 2008 Oct; 31(10):1544-7. PubMed ID: 19230412
[TBL] [Abstract][Full Text] [Related]
38. Renin-angiotensin system inhibitors in proteinuric chronic kidney disease.
Hirsch S
Compr Ther; 2009; 35(2):91-5. PubMed ID: 19618757
[TBL] [Abstract][Full Text] [Related]
39. [Renin-angiotensin system modulation: instructions for use].
Bellis A; Rozza F; Crispo S; Trimarco B
G Ital Cardiol (Rome); 2008 Feb; 9(2):79-89. PubMed ID: 18383770
[TBL] [Abstract][Full Text] [Related]
40. New biscoumarin derivatives-cytotoxicity and enzyme inhibitory activities.
Choudhary MI; Fatima N; Khan KM; Jalil S; Iqbal S; Atta-Ur-Rahman
Bioorg Med Chem; 2006 Dec; 14(23):8066-72. PubMed ID: 16919464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
